These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26454259)

  • 1. Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis.
    Coupé P; Fonov VS; Bernard C; Zandifar A; Eskildsen SF; Helmer C; Manjón JV; Amieva H; Dartigues JF; Allard M; Catheline G; Collins DL;
    Hum Brain Mapp; 2015 Dec; 36(12):4758-70. PubMed ID: 26454259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.
    Gerischer LM; Fehlner A; Köbe T; Prehn K; Antonenko D; Grittner U; Braun J; Sack I; Flöel A
    Neuroimage Clin; 2018; 18():485-493. PubMed ID: 29527504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of Alzheimer's disease using MRI hippocampal texture.
    Sørensen L; Igel C; Liv Hansen N; Osler M; Lauritzen M; Rostrup E; Nielsen M;
    Hum Brain Mapp; 2016 Mar; 37(3):1148-61. PubMed ID: 26686837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
    Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
    Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved prediction of Alzheimer's disease with longitudinal white matter/gray matter contrast changes.
    Grydeland H; Westlye LT; Walhovd KB; Fjell AM
    Hum Brain Mapp; 2013 Nov; 34(11):2775-85. PubMed ID: 22674625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume.
    Lee S; Lee H; Kim KW;
    J Psychiatry Neurosci; 2020 Jan; 45(1):7-14. PubMed ID: 31228173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting.
    Suppa P; Anker U; Spies L; Bopp I; Rüegger-Frey B; Klaghofer R; Gocke C; Hampel H; Beck S; Buchert R
    J Alzheimers Dis; 2015; 44(1):183-93. PubMed ID: 25201782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
    Mielke MM; Okonkwo OC; Oishi K; Mori S; Tighe S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2012; 8(2):105-13. PubMed ID: 22404852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
    van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
    JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.